• Immune Signatures of Epigenetic Modulation in Melanoma

  2026-05-19

  Anichini et al. systematically profiled how diverse epigenetic inhibitors modulate immune-related gene expression in melanoma, revealing that the DNA methyltransferase inhibitor guadecitabine robustly upregulates innate and adaptive immune signatures. These findings guide combinatorial immunotherapy strategies and underscore the importance of rational drug selection in translational cancer research.

• WM-8014: Precision KAT6A Inhibition for Senescence Profiling

  2026-05-18

  Explore how WM-8014, a potent KAT6A inhibitor, enables advanced, artifact-free profiling of oncogene-induced senescence and selective cell cycle arrest. This article unveils practical workflow guidance and the latest insights from CRISPR-enabled epigenetic research.

• Dehydroepiandrosterone (DHEA): Applied Protocols in Neuropro

  2026-05-18

  Dehydroepiandrosterone (DHEA) empowers researchers with robust, evidence-driven workflows for neuroprotection and reproductive biology. This guide translates the latest mechanistic insights and protocol enhancements into actionable steps—maximizing reproducibility and innovation across cell and animal models.

• LuQi Formula Inhibits SPTLC2-Mediated Ceramide Synthesis Aft

  2026-05-17

  The highlighted study demonstrates that the LuQi Formula attenuates ventricular remodeling following myocardial infarction by suppressing SPTLC2-regulated de novo ceramide synthesis. These findings clarify a novel mechanistic link between herbal intervention and sphingolipid metabolism, providing actionable insight for translational cardiac research.

• Ginkgo Biloba Compound Cocktail Boosts Yeast Mitochondrial L

  2026-05-16

  This study leverages network pharmacology to identify a synergistic four-compound cocktail from Ginkgo biloba extract that significantly enhances mitochondrial function and extends chronological lifespan in yeast. The findings provide a mechanistic framework for designing multi-component anti-aging strategies targeting mitochondrial health.

• Reliable Assays with 5,6-Dichloro-1-β-D-ribofuranosyl-1H-ben

  2026-05-15

  This article provides scenario-driven guidance for integrating 5,6-dichloro-1-β-D-ribofuranosyl-1H-benzimidazole (DRB, SKU C4798) into cell viability and transcriptional assays. Researchers will find evidence-based best practices, protocol parameters, and vendor selection criteria to improve reproducibility and data integrity in advanced biomedical workflows.

• Deferasirox Modulates Myeloid Maturation via NF-κB and Mitoc

  2026-05-15

  This study elucidates how the iron chelator Deferasirox (Exjade) alters myeloid cell differentiation by modulating mitochondrial reactive oxygen species (ROS) and the NF-κB signaling pathway. The findings reveal stage-specific effects on progenitor and neutrophil populations, offering mechanistic insight relevant to iron overload treatment research and myelodysplastic syndrome (MDS) therapy.

• Double-Strand Breaks Trigger Short-Scale BIR in Mouse Oocyte

  2026-05-14

  This study reveals that double-strand DNA breaks in fully grown mouse oocytes induce a previously uncharacterized form of short-scale break-induced replication (ssBIR), amplifying DNA damage. The work provides mechanistic insight into genome stability risks in germline cells and demonstrates how DNA polymerase inhibitors like ddATP modulate DNA repair processes.

• Quercetin Mitigates Neuroinflammation in LPS-Induced Depress

  2026-05-14

  This study demonstrates that quercetin attenuates depressive-like behaviors and cognitive deficits in a mouse model of LPS-induced depression by suppressing hippocampal NLRP3 inflammasome activation and neuroinflammatory cytokine release. The findings provide mechanistic insight into quercetin’s dual neuroprotective and antidepressant-like effects, supporting its further exploration as a research tool in neuroinflammation and mood disorder studies.

• Liproxstatin-1 HCl: Reliable Ferroptosis Inhibition for Assa

  2026-05-13

  This article delivers evidence-based guidance for implementing Liproxstatin-1 HCl (SKU B8221) in ferroptosis assays and acute injury models. Through scenario-driven analysis, it addresses key experimental challenges, protocol optimization, and product selection, equipping researchers with best practices anchored in reproducibility and validated performance.

• BI 2536 as a PLK1 Inhibitor: Applied Cancer Research Workflo

  2026-05-13

  BI 2536 empowers researchers to dissect mitotic checkpoint control, induce precise G2/M cell cycle arrest, and drive apoptosis in cancer models with nanomolar potency. This article offers protocol-ready guidance, troubleshooting insights, and new strategies derived from the latest mechanistic breakthroughs in PLK1 inhibition.

• Baicalein (5,6,7-trihydroxy-2-phenylchromen-4-one): Elevatin

  2026-05-12

  Explore how Baicalein, a potent 12-LOX pathway inhibitor, advances apoptosis and inflammation research beyond standard protocols. This article offers a deep scientific dive, unique mechanistic insights, and actionable guidance for leveraging Baicalein’s molecular properties in cutting-edge assays.

• Y-27632 Dihydrochloride: Optimizing ROCK Inhibitor Workflows

  2026-05-12

  Y-27632 dihydrochloride empowers researchers to precisely modulate Rho/ROCK signaling—unlocking breakthroughs in stem cell viability, cytoskeletal studies, and tumor invasion assays. Learn how to integrate this selective ROCK inhibitor into advanced experimental systems, streamline troubleshooting, and build on innovations in gut neuro-epithelial modeling.

• Cy5 TSA Fluorescence System Kit: Precision in Spatial Proteo

  2026-05-11

  Discover how the Cy5 TSA Fluorescence System Kit enables ultra-sensitive, spatially resolved protein detection for advanced immunohistochemistry and in situ hybridization. This article uniquely connects TSA technology to the latest breakthroughs in spatial proteome profiling.

• Trichinella spiralis Antigens Alleviate PEDV Damage in Porci

  2026-05-11

  This study demonstrates that Trichinella spiralis excretory/secretory antigens (TsES) reduce inflammation and promote mucosal barrier repair in porcine intestinal organoids infected with porcine epidemic diarrhea virus (PEDV). The work introduces a robust organoid model for dissecting host-virus-parasite interactions and suggests that parasite derivatives could serve as adjunctive therapies for intestinal inflammation.

15931 records 1/1063 page Next 12345 下5页 Last page